Gates Foundation’s LumiraDx Limited Common Shares LMDX Stock Holding History

Gates Foundation’s Portfolio LMDX Stock Details LMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-14,285,714	Closed	-$143K	–	8
2024 Q1	$143K	Hold	14,285,714	–	–	0.17%	7
2023 Q4	$857K	Hold	14,285,714	–	–	0.95%	7
2023 Q3	$3.43M	Hold	14,285,714	–	–	4.09%	6
2023 Q2	$6.86M	Hold	14,285,714	–	–	5.46%	6
2023 Q1	$6.71M	Hold	14,285,714	–	–	5.93%	6
2022 Q4	$12.9M	Hold	14,285,714	–	–	9.91%	4
2022 Q3	$14.6M	Buy	+14,285,714	New	+$23.7M	11.54%	4
2022 Q2	–	Sell	-5,574,059	Closed	-$33.4M	–	11
2022 Q1	$33.4M	Hold	5,574,059	–	–	17.96%	3
2021 Q4	$49.7M	Hold	5,574,059	–	–	15.08%	3
2021 Q3	$46.1M	Buy	+5,574,059	New	+$45.2M	13.5%	2

Gates Foundation's LMDX Position: Q2 2024 in Review

Gates Foundation sold out of LumiraDx Limited Common Shares (LMDX) in Q2 2024, closing a stake of 14,285,714 shares — an estimated $143K sold.

Gates Foundation first reported a position in LMDX in Q3 2021 and held it in 10 quarters. The position peaked at $49.7M in Q4 2021. 0 funds tracked by Wall St. Rank hold LMDX as of Q2 2024.

Gates Foundation reported no remaining LumiraDx Limited Common Shares position as of Q2 2024 after selling out during the quarter.
Gates Foundation sold 14,285,714 LumiraDx Limited Common Shares shares in Q2 2024, an estimated $143K.
Gates Foundation first reported a position in LumiraDx Limited Common Shares in Q3 2021 and held it in 10 quarters.
Gates Foundation's LumiraDx Limited Common Shares position peaked at $49.7M in Q4 2021.
0 funds tracked by Wall St. Rank held LumiraDx Limited Common Shares as of Q2 2024.

Based on Gates Foundation's 13F filing for Q2 2024, filed 14 Aug 2024.